A modern clinic for at-home treatments
(857) 240-1080
! Not medical advice. Consult a doctor.







Reslizumab, marketed under the name Cinqair, is a medication classified as a monoclonal antibody. It is an interleukin-5 (IL-5) antagonist, which specifically targets and mitigates the effects of IL-5, a cytokine responsible for the growth, differentiation, recruitment, activation, and survival of eosinophils. By inhibiting IL-5, Reslizumab plays a pivotal role in controlling conditions associated with high levels of eosinophils.
Drug Category
What it is Used For
Reslizumab is primarily used as an add-on maintenance therapy. This means it is not a standalone treatment but is used in conjunction with other medications to manage certain conditions more effectively.
What it Treats
The primary condition treated by Reslizumab is severe eosinophilic asthma. Patients with this type of asthma experience chronic inflammation in their airways due to an overabundance of eosinophils, leading to frequent and severe asthma attacks. Reslizumab helps to:
Why settle for temporary relief? Try immunotherapy for lasting results!
Am I eligible?
Reslizumab, marketed as Cinqair, is a medication primarily used to treat certain conditions related to eosinophilic asthma. It is tailored for a specific subset of asthma patients whose symptoms are not adequately controlled with conventional treatments. Below are the key conditions that Reslizumab addresses.
Severe Eosinophilic Asthma
Uncontrolled Asthma Symptoms
Reslizumab is specifically designed for patients whose asthma is not well-controlled with inhaled corticosteroids and other standard medications and is not meant for the treatment of other types of asthma or allergic conditions. Always consult with healthcare professionals prior to considering this treatment option to ensure its appropriateness for your specific medical condition.
Find out if immunotherapy is right for you

Introduction to Reslizumab (Cinqair)
Benefits of Reslizumab
Supportive Evidence
Conclusion

Possible Side Effects of Reslizumab (Cinqair)
Safety Precautions When Using Reslizumab (Cinqair)
A safer solution to allergies: try immunotherapy today!

When evaluating the merits of immunotherapy compared to Reslizumab (Cinqair) for allergy treatment, it's essential to consider the long-term implications, versatility, and the mechanism of action that underlie both treatments.
Mechanism of Action
Scope of Treatment
Long-term Outcomes
Treatment Duration and Commitment
Potential Side Effects
Ultimately, the choice between immunotherapy and Reslizumab (Cinqair) should be guided by the patient's specific health needs, the nature of their allergic condition, and a thorough discussion with an allergist or healthcare provider.

Treatment prescribed
by clinician


Clinicaly made allergen extracts are customized for your allergies


Your immune system gets desensitized to allergens, giving you long-term relief.
Medical disclaimer.
This page is for educational purposes only and is not medical advice, diagnosis, or treatment. It is not a substitute for consultation with a licensed healthcare provider. Always talk to a qualified clinician before starting, stopping, or changing any allergy treatment. Outcomes from allergy immunotherapy vary from patient to patient. Response rates, symptom-reduction percentages, timelines, and pricing referenced on this page are based on peer-reviewed literature, clinical guidelines, and current Curex membership plans at the time of review - they are population averages or current offers, not a prediction of individual results, and are subject to change. Eligibility for any treatment is determined by a licensed clinician on a case-by-case basis. Cntent reviewed by a licensed clinician. References to third-party products, brand names, or competitor services are for educational comparison only and do not imply endorsement.